The collaboration comes a year after Vironix announced its partnership with Oxford University to develop novel prediction methods for proactive intervention in congestive heart failure.

AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- Vironix Health Inc., an innovative leader in AI-powered remote patient monitoring applications for healthcare providers, is bolstering its alliance with the University of Oxford's Mathematical Institute. The collaboration aims squarely at advanced prediction of Chronic Kidney Disease (CKD) progression.Oxford UniversityBuilding on the triumph of last year's synthetic patient data generation project, the partners are setting their sights on CKD, a medical challenge marked by gradual kidney function deterioration. Early interventions leveraging AI can amplify patient well-being, decelerate the disease progression, and reduce healthcare costs. Dr. Sumanth Swaminathan, CEO of Vironix Health, commented on the partnership's potential, remarking, "Vironix is committed to innovating preventive care technologies that prioritize validation through scientific rigor and peer review

Vironix Health, a digital health company, has announced the appointment of Mahesh Visvanathan, MS/MBA as Chief Operations and Business Development Officer to lead its strategic partnership and commercialization strategy.